Startseite Quality of interpretative commenting on common clinical chemistry results in the Asia-Pacific region and Africa
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Quality of interpretative commenting on common clinical chemistry results in the Asia-Pacific region and Africa

  • Samuel D. Vasikaran , Leslie C. Lai , Sunil Sethi , Joseph B. Lopez und Kenneth A. Sikaris
Veröffentlicht/Copyright: 10. Juli 2009
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: Interpretative commenting is an important activity of the clinical diagnostic laboratory. We describe a study of interpretative commenting abilities among senior laboratory professionals in the Asia-Pacific region and Africa.

Methods: Five sets of laboratory results reflecting common and important problems encountered in clinical chemistry were distributed at 4-weekly intervals to 31 registered participants from countries in the Asia-Pacific region and Africa. Participants were asked to attach an interpretative comment to the results assuming that the requesting doctor had asked for an interpretation of the result.

Results: Twelve pathologists and 19 scientists from seven countries registered to participate and the overall reply rate was ∼50% for the five cases. The quality of the comments returned by participants was diverse and some reflected incorrect or misleading interpretation and advice.

Conclusions: While interpretative commenting is an important laboratory activity, the results of this study suggest that there is room for improvement in the quality of interpretative comments offered by senior laboratory professionals, even for commonly reported results relating to most prevalent and important public health conditions. Interpretative commenting should be formally taught during training of pathologists and scientists, and continuing professional development in this area is required for the provision of a quality interpretative service.

Clin Chem Lab Med 2009;47:963–70.


Corresponding author: Dr. Samuel D. Vasikaran, Department of Core Clinical Pathology and Biochemistry, Royal Perth Hospital, Box X2213 GPO, Perth, WA 6847, Australia Phone: +61 8 9224 2453, Fax: +61 8 9224 1789,

Received: 2009-4-15
Accepted: 2009-5-25
Published Online: 2009-07-10
Published in Print: 2009-08-01

©2009 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Editorial
  2. Hemolysis index: quality indicator or criterion for sample rejection?
  3. Review
  4. Neutrophil CD64: a diagnostic marker for infection and sepsis
  5. Genetics and Molecular Diagnostics
  6. Chromosome 9p21 polymorphism is associated with myocardial infarction but not with clinical outcome in Han Chinese
  7. Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia
  8. Clinical, biochemical, and genetic analysis of a Korean neonate with hereditary tyrosinemia type 1
  9. General Clinical Chemistry and Laboratory Medicine
  10. Multicenter evaluation of the hemolysis index in automated clinical chemistry systems
  11. Haemolysis index – an estimate of preanalytical quality in primary health care
  12. Evaluation of the Innovance D-DIMER analytical performance
  13. Heterophile antibodies may falsely increase or decrease thyroglobulin measurement in patients with differentiated thyroid carcinoma
  14. Variation of barrier permeability for albumin and immunoglobulin G influx into cerebrospinal fluid
  15. Anti-citrullinated protein antibody and rheumatoid factor in patients with end-stage renal disease
  16. Reference Values and Biological Variations
  17. Quality of interpretative commenting on common clinical chemistry results in the Asia-Pacific region and Africa
  18. Analysis and interpretation of drug testing results from patients on chronic pain therapy: a clinical laboratory perspective
  19. Cancer Diagnostics
  20. HER1-4 protein concentrations in normal breast tissue from breast cancer patients are expressed by the same profile as in the malignant tissue
  21. Comparison of fifteen immunoassays for the measurement of serum MUC-1/CA 15-3 in breast cancer patients
  22. Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers
  23. Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma
  24. Relationship of serum antioxidant micronutrients and sociodemographic factors to cervical neoplasia: a case-control study
  25. Letters to the Editor
  26. Clinical efficacy of two cardiac troponin I assays
  27. Impeded centrifugation in plasmocytoma serum
Heruntergeladen am 23.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.225/pdf?lang=de
Button zum nach oben scrollen